Toward a Mechanistic Framework for Adaptogenic Action: A Multilevel Evidence Synthesis for Hydroponically Cultivated Red Panax ginseng (HRG80)

Background: The adaptogen concept, first formalized over half a century ago, describes pharmacological agents that increase nonspecific resistance to stress. Despite extensive clinical evidence supporting the efficacy of adaptogenic botanicals, the concept has re-mained largely phenomenological, lacking a mechanistic framework compatible with modern molecular pharmacology. This has limited its acceptance in evidence-based medi-cine. Aims: We propose that hydroponically cultivated red Panax ginseng preparation HRG80, with its chemically reproducible composition and multilevel evidence base, constitutes a case study through which the mechanistic basis of adaptogenic action can be examined across molecular, cellular, neurophysiological, and clinical levels. Methods: We identified all published preclinical and clinical studies conducted on HRG80 through PubMed, Scopus, and manual citation tracking (last search: March 2026). Ten published studies met the inclusion criterion, including three randomized, dou-ble-blind, placebo-controlled clinical trials and two open-label trials, encompassing ap-proximately 440 human subjects. One manuscript in preparation and one unpublished preclinical gut-brain axis dataset were included with appropriate caveats. We integrated transcriptomic, electrophysiological, in vitro, in vivo, and clinical evidence into a pro-posed mechanistic model. Results: The converging evidence supports a three-tier temporal model of adaptogenic ac-tion. The acute tier (minutes to hours) involves modulation of NMDA and Kainate gluta-mate receptors, enhancing hippocampal long-term potentiation. The subacute tier (days to weeks) involves activation of CREB signaling and the slit-robo axonal guidance pathway, producing structural neuroplasticity functionally equivalent to brain-derived neu-rotrophic factor stimulation. The chronic tier (weeks to months), based on in vitro evidence in non-neuronal models, involves DNMT inhibition and epigenetic reprogramming, sug-gesting a potential mechanism for durable changes in cellular stress resilience. Tran-scriptomic analysis identified 1,061 genes uniquely modulated by the whole extract and not by isolated ginsenosides, consistent with the hypothesis that the adaptogenic effect is an emergent property of the phytochemical network. Preliminary preclinical data from a gut-brain axis model suggest that HRG80 protects intestinal barrier integrity and attenu-ates neuroinflammation, providing a plausible systemic pathway from oral intake to cen-tral effects. Conclusion: HRG80 provides convergent multilevel evidence suggesting that adaptogenic nonspecificity may reflect a hierarchically organized multi-specificity operating across distinct temporal scales. If confirmed by independent replication and further mechanistic studies, this framework could offer a template for the systematic investigation of other adaptogenic botanicals.